Fatigue is associated with high circulating leptin levels in chronic hepatitis C

Background and aims: Fatigue is a frequent and disabling symptom reported by patients with chronic hepatitis C (CHC). Its mechanism is poorly understood. Recent attention has focused on the role of leptin and energy expenditure in CHC. Our aims were to analyse fatigue in CHC and to determine its relationship with disease activity, resting energy expenditure (REE), circulating leptin, and tumour necrosis factor α (TNF-α). Methods: Seventy eight CHC patients, 22 healthy controls, and 13 primary biliary cirrhosis (PBC) patients underwent measurements of REE, body composition, leptin, and TNF-α. All subjects completed the fatigue impact scale (FIS) questionnaire. A liver biopsy and viral load measurements were performed in all patients. Results: Thirty eight of 78 CHC patients considered fatigue the worst or initial symptom of their disease. The fatigue score of patients was significantly higher than that of controls (53.2 (40.1) v 17.7 (16.9); p<0.0001) and was more pronounced in females (p=0.003). Leptin was increased significantly in CHC patients compared with controls (15.4 (20.7) v 6.4 (4.1) ng/ml; p<0.05). In CHC patients, the fatigue score correlated significantly with leptin corrected for fat mass (r=0.30, p=0.01). This correlation increased when the physical domain of fatigue was included (r=0.39, p=0.0009). Furthermore, a similar positive correlation was found in PBC patients (r=0.56, p=0.04). No correlation was found between fatigue and age, REE, liver function tests, viral load, or the METAVIR score in CHC patients. Conclusions: Fatigue is present in CHC patients and is more pronounced in females. The FIS questionnaire is clinically relevant and may be useful for future therapeutic trials aimed at reducing fatigue. Fatigue may be partly mediated by leptin.

[1]  A. Hamann,et al.  Regulation of energy balance by leptin. , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[2]  B. Nguyen,et al.  Assessment of Fatigue in Patients with Chronic Hepatitis C Using the Fatigue Impact Scale , 2002, Digestive Diseases and Sciences.

[3]  P. Cacoub,et al.  Fatigue in patients with chronic hepatitis C , 2002, Journal of viral hepatitis.

[4]  M. Manns,et al.  Elevated bound leptin correlates with energy expenditure in cirrhotics. , 2000, Gastroenterology.

[5]  H. Tilg,et al.  Cytokines in alcoholic and nonalcoholic steatohepatitis. , 2000, The New England journal of medicine.

[6]  R. Gorczynski,et al.  Serum cytokine values and fatigue in chronic hepatitis C infection , 2000, Journal of viral hepatitis.

[7]  P. Rampal,et al.  Resting energy expenditure in chronic hepatitis C. , 2000, Journal of hepatology.

[8]  R. Testa,et al.  Serum leptin levels in patients with viral chronic hepatitis or liver cirrhosis. , 2000, Journal of hepatology.

[9]  G. Mingrone,et al.  Serum leptin levels in post-hepatitis liver cirrhosis. , 2000, Journal of hepatology.

[10]  Z. Younossi,et al.  Hepatitis C, interferon alfa, and depression , 2000, Hepatology.

[11]  D. Papanicolaou,et al.  Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. , 2000, The Journal of clinical endocrinology and metabolism.

[12]  A. Tran,et al.  Impact of fatigue on the quality of life of patients with primary biliary cirrhosis , 2000, American Journal of Gastroenterology.

[13]  M. Swain,et al.  Progressive development of a Th1‐type hepatic cytokine profile in rats with experimental cholangitis , 2000, Hepatology.

[14]  M. Buemi,et al.  Leptin increases serotonin turnover by inhibition of brain nitric oxide synthesis. , 1999, The Journal of clinical investigation.

[15]  R. Moss,et al.  TNF-α and Chronic Fatigue Syndrome , 1999, Journal of Clinical Immunology.

[16]  J. Crowe,et al.  Fatigue does not correlate with the degree of hepatitis or the presence of autoimmune disorders in chronic hepatitis C infection. , 1999, European journal of gastroenterology & hepatology.

[17]  J. Holst,et al.  Increased circulating leptin in alcoholic cirrhosis: Relation to release and disposal , 1999, Hepatology.

[18]  S. Anker,et al.  Insights into the pathogenesis of chronic heart failure: immune activation and cachexia. , 1999, Current opinion in cardiology.

[19]  T. Nagamine,et al.  An increase of circulating leptin in patients with liver cirrhosis , 1998, International Journal of Obesity.

[20]  R. Schmidt,et al.  Bound leptin is regulated by tumour necrosis factor-alpha in HIV-infected patients: a potential mediator of wasting? , 1998, AIDS.

[21]  G. Marchesini,et al.  Gender-dependent alterations in serum leptin in alcoholic cirrhosis. , 1998, Gastroenterology.

[22]  N. Christensen,et al.  The sympathetic nervous system in liver disease. , 1998, Journal of hepatology.

[23]  K. Nakao,et al.  Satiety effect and sympathetic activation of leptin are mediated by hypothalamic melanocortin system , 1998, Neuroscience Letters.

[24]  D. Beezhold,et al.  Elevated levels of tumor necrosis factor alpha in postdialysis fatigue , 1998, The International journal of artificial organs.

[25]  H. Thomas,et al.  Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis , 1998, Hepatology.

[26]  G. Davis,et al.  Activation of Tumor Necrosis Factor-α System in Chronic Hepatitis C Virus Infection , 1997, Digestive Diseases and Sciences.

[27]  C. Mantzoros,et al.  Human leptin levels are pulsatile and inversely related to pituitary–ardenal function , 1997, Nature Medicine.

[28]  R. Considine,et al.  Leptin: The Tale of an Obesity Gene , 1996, Diabetes.

[29]  J. Friedman,et al.  Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. , 1996, The Journal of clinical investigation.

[30]  E. Jones Fatigue associated with chronic liver disease: A riddle wrapped in a mystery inside an enigma , 1995, Hepatology.

[31]  M. Swain,et al.  Defective corticotropin‐releasing hormone mediated neuroendocrine and behavioral responses in cholestatic rats: Implications for cholestatic liver disease–related sickness behaviors , 1995, Hepatology.

[32]  S. Chopra,et al.  Hepatitis C: A Multifaceted Disease: Review of Extrahepatic Manifestations , 1995, Annals of Internal Medicine.

[33]  M. Pelleymounter,et al.  Effects of the obese gene product on body weight regulation in ob/ob mice. , 1995, Science.

[34]  M. Tong,et al.  Clinical outcomes after transfusion-associated hepatitis C. , 1995, The New England journal of medicine.

[35]  P. Bedossa,et al.  Intraobserver and Interobserver Variations in Liver Biopsy Interpretation in Patients with Chronic Hepatitis C , 1994 .

[36]  W. Souba Cytokine control of nutrition and metabolism in critical illness. , 1994, Current problems in surgery.

[37]  C. Dinarello,et al.  Gender differences in IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist secretion from mononuclear cells and urinary excretion. , 1994, Journal of immunology.

[38]  J. Fisk,et al.  The Impact of Fatigue on Patients with Multiple Sclerosis , 1994, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[39]  H. Lautz,et al.  Energy expenditure and substrate oxidation in patients with cirrhosis: The impact of cause, clinical staging and nutritional state , 1992, Hepatology.

[40]  A. Thomasset,et al.  Fat-free mass estimation by the two-electrode impedance method. , 1990, The American journal of clinical nutrition.

[41]  J. B. Weir New methods for calculating metabolic rate with special reference to protein metabolism , 1949, The Journal of physiology.

[42]  S. Warmington,et al.  Functional and histological characteristics of skeletal muscle and the effects of leptin in the genetically obese (ob/ob) mouse , 2000, International Journal of Obesity.

[43]  R. Moss,et al.  TNF-alpha and chronic fatigue syndrome. , 1999, Journal of clinical immunology.

[44]  G. Davis,et al.  Activation of tumor necrosis factor-alpha system in chronic hepatitis C virus infection. , 1997, Digestive diseases and sciences.

[45]  D. Graham,et al.  Task force on training in acid-peptic disease , 1996 .

[46]  T. Marrie,et al.  Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.